莊 喬雄

Medicine & Life Sciences

1. Helicobacter pylori 100%
2. Inflammatory Bowel Diseases 68%
3. Helicobacter Infections 65%
4. Omeprazole 63%
5. Hepatocellular Carcinoma 58%
6. Crohn Disease 54%
7. Stomach 53%
8. Pylorus 45%
9. Hemorrhage 36%
10. Peptic Ulcer 33%
11. Sorafenib 27%
12. Endoscopy 26%
13. Acute Cholecystitis 25%
14. Survival 25%
15. Dyspepsia 25%
16. Ulcerative Colitis 24%
17. Metaplasia 24%
18. Amoxicillin 24%
19. Mucous Membrane 22%
20. Inflammation 22%
21. Infections 22%
22. Therapeutics 21%
23. Gastrectomy 21%
24. Ascorbic Acid 20%
25. Breath Tests 20%
26. Antifoaming Agents 20%
27. Liver 19%
28. ranitidine bismuth citrate 18%
29. Gallbladder 17%
30. Gastritis 17%
31. Guidelines 17%
32. Hepatic Infarction 17%
33. Retrospective Studies 16%
34. Ultrasonography 16%
35. Histology 16%
36. vedolizumab 16%
37. Radiofrequency Therapy 16%
38. Biological Products 16%
39. Urea 15%
40. Endoscopic Hemostasis 15%
41. SARS Virus 15%
42. Esomeprazole 15%
43. Protein-Tyrosine Kinases 14%
44. Meckel Diverticulum 14%